Haber Philipp Konstantin, Wabitsch Simon, Krenzien Felix, Benzing Christian, Andreou Andreas, Schöning Wenzel, Öllinger Robert, Pratschke Johann, Schmelzle Moritz
Department of Surgery, Campus Charité Mitte and Campus Virchow-Klinikum, Charité - Universitätsmedizin, Berlin, Germany.
Department of Surgery, Campus Charité Mitte and Campus Virchow-Klinikum, Charité - Universitätsmedizin, Berlin, Germany; Berlin Institute of Health (BIH), Berlin, Germany.
Surg Oncol. 2019 Mar;28:140-144. doi: 10.1016/j.suronc.2018.12.001. Epub 2018 Dec 14.
Minimal-invasive liver resection has gained considerable attention in recent years, assuming a weighty position in the field of HPB surgery. Even lesions in posterosuperior segments, the technically most challenging localization, have been resected while achieving comparable outcomes to laparotomy. The objective of this study is to evaluate whether the similar beneficial results can be conveyed through minimal-invasive techniques for patients with liver cirrhosis.
We retrospectively analyzed all consecutive patients undergoing laparoscopic liver resection with at least one lesion in the posterosuperior liver segments (IVa, VII, VIII) at our center between January 2012 and July 2018. Patients were separated in two groups based on the presence (n = 43) or absence (n = 115) of liver cirrhosis.
Preoperative patient characteristics showed that patients with cirrhosis were older (p < 0.001), had more frequently diabetes (p < 0.005) and a history of alcohol consumption (p < 0.0005). Preoperative liver function, as assessed by LiMAx score was markedly decreased in patients with liver cirrhosis (p < 0.005). While a similar percentage in both groups had anatomical resection, significantly more major resections were performed in patients without cirrhosis (cirrhosis: 23.3% vs. no cirrhosis 55.7%; p < 0.0005). Consequently, surgeries were markedly longer in the no cirrhosis group (p < 0.0005). There was no difference with regard to the need for perioperative transfusion or conversion to laparotomy. There was no differences found between both groups with regard to the postoperative course showing similar ICU- and hospital stays. Complication rate, both with regard to minor and major complications, as well as rate of clear resection margins were similar between the two groups as well.
Patients with liver cirrhosis and a lesion in the posterosuperior liver segments are amenable to the minimal-invasive approaches as no significant differences can be observed with regard to safety and oncologic sufficiency. As these procedures are from a technical perspective challenging, they should be performed in specialized centers.
近年来,微创肝切除术受到了广泛关注,在肝胰胆外科领域占据重要地位。即使是位于肝后上段(技术上最具挑战性的部位)的病变,也已通过该技术进行切除,且疗效与开腹手术相当。本研究的目的是评估对于肝硬化患者,微创技术是否能带来类似的良好效果。
我们回顾性分析了2012年1月至2018年7月期间在我院中心接受腹腔镜肝切除术且肝后上段(IVa、VII、VIII段)至少有一个病变的所有连续患者。根据是否存在肝硬化将患者分为两组(肝硬化组n = 43,无肝硬化组n = 115)。
术前患者特征显示,肝硬化患者年龄更大(p < 0.001),糖尿病患病率更高(p < 0.005),且有饮酒史(p < 0.0005)。通过LiMAx评分评估的术前肝功能在肝硬化患者中显著降低(p < 0.005)。两组中进行解剖性切除的比例相似,但无肝硬化患者进行的大手术明显更多(肝硬化组:23.3% vs. 无肝硬化组55.7%;p < 0.0005)。因此,无肝硬化组的手术时间明显更长(p < 0.0005)。围手术期输血需求或转为开腹手术方面无差异。两组术后病程相似,ICU住院时间和住院时间相近。两组的轻微和严重并发症发生率以及切缘阴性率也相似。
肝后上段有病变的肝硬化患者适合采用微创方法,因为在安全性和肿瘤学充分性方面未观察到显著差异。由于这些手术从技术角度具有挑战性,应在专业中心进行。